Compounds > fucose

fucose and Bile Duct Cancer

fucose has been researched along with Bile Duct Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Brindley, PJ; Chamgramol, Y; Deenonpoe, R; Pairojkul, C; Sripa, B; Suttiprapa, S; Thanaphongdecha, P1
Bai, T; Hong, G; Hou, X; Liu, J; Qian, W; Zheng, J; Zhu, B1
Ament, CE; Banales, JM; Calvisi, DF; Chen, X; Evert, K; Evert, M; Giannelli, G; Gigante, I; Olaizola, P; Pes, GM; Pizzuto, E; Ribback, S; Rodrigues, PM; Steinmann, S; Wang, H1
Dana, P; Indramanee, S; Kariya, R; Klinhom-On, N; Okada, S; Phoomak, C; Sawanyawisuth, K; Silsirivanit, A; Sorin, S; Wongkham, C; Wongkham, S1
Betesh, L; Block, TM; Comunale, MA; Giama, NH; Hafner, J; Karabudak, A; Liang, H; Mehta, A; Miyoshi, E; Moser, CD; Roberts, LR; Wang, M1

Other Studies

5 other study(ies) available for fucose and Bile Duct Cancer

ArticleYear
Adherence of
    Parasitology, 2022, Volume: 149, Issue:10

    Topics: Adult; Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Epithelium; Fucose; Helicobacter pylori; Humans; Opisthorchis

2022
L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression.
    Chinese medical journal, 2022, Dec-20, Volume: 135, Issue:24

    Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; Endothelial Cells; Fucose; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Mitogen-Activated Protein Kinase 7; STAT3 Transcription Factor

2022
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
    Hepatology (Baltimore, Md.), 2023, Dec-01, Volume: 78, Issue:6

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; ErbB Receptors; Fucose; Glycosylation; Humans; NF-kappa B; Prognosis

2023
Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.
    Scientific reports, 2019, 11-21, Volume: 9, Issue:1

    Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Progression; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; ErbB Receptors; Female; Fucose; Fucosyltransferases; Galactoside 2-alpha-L-fucosyltransferase; Humans; Male; MAP Kinase Signaling System; Middle Aged; Proto-Oncogene Proteins c-akt; Signal Transduction; Transcriptome

2019
Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma.
    Proteomics. Clinical applications, 2017, Volume: 11, Issue:9-10

    Topics: alpha-2-HS-Glycoprotein; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Female; Fucose; Glycosylation; Humans; Male; Middle Aged; Proteomics

2017